AKR1B1 and breast carcinoma: Accordingly, when we analyzed public databases, we found that breast cancer patients with high AK1B1 mRNA levels displayed a significant reduction in overall survival, with a survival probability of 0.807 and 0.872 for patients expressing high and low AKR1B1 mRNA, respectively (n = 2976, Figure 4A).